Connection

DAVID LONARD to Pyrimidines

This is a "connection" page, showing publications DAVID LONARD has written about Pyrimidines.
Connection Strength

0.024
  1. Inhibition of SRC-3 as a potential therapeutic strategy for aggressive mantle cell lymphoma. PLoS One. 2024; 19(4):e0289902.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.